Brief: Moberg Pharma Q3 EBITDA Loss Narrows To SEK 4.0 Million

Moberg Pharma AB (publ)

09/11/2021 07:08

Nov 9 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q3 EBITDA LOSS  SEK 4.0 MILLION VERSUS LOSS SEK 4.6
MILLION YEAR
AGO

Source text for Eikon:  ID:nWkr78jk3x 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))